
    
      Study process is as follows.

        1. Informed consent for subjects fulfilling the inclusion criteria.

        2. Laboratory evaluation will be done for subjects according to the following diagnostic
           criteria.

             -  Diagnosis will be established if one of either 1 or 2 below is fulfilled

                  1. A molecular diagnosis consistent with HLH

                  2. Diagnostic criteria for HLH fulfilled (5 out of 8 criteria below)

             -  fever ≥ 38.5'C for ≥ 7 days

             -  splenomegaly ≥ 3 finger breadth below left subcostal margin

             -  cytopenias affecting ≥2 of 3 lineages in peripheral blood (Hemoglobin < 9 g/L,
                Platelets < 100 × 109/L, Absolute neutrophil count < 1.0 × 109/L)

             -  Hypertriglyceridemia and/or hypofibrinogenemia: Fasting triglycerides ≥ 265 mg/dL,
                fibrinogen ≤ 1.5 g/L

             -  Hemophagocytosis in bone marrow or spleen or lymph node

             -  Low or absent NK-cell activity (according to local laboratory reference)

             -  Ferritin ≥ 500 mcg/L

             -  Soluble CD25 (sIL-2 receptor) ≥ 2,400 U/mL
    
  